These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11891510)

  • 1. Genetics of programmed cell death and proliferation.
    Orlov SN; Tremblay J; Deblois D; Hamet P
    Semin Nephrol; 2002 Mar; 22(2):161-71. PubMed ID: 11891510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation and apoptosis of vascular smooth muscle in hypertension.
    Hamet P
    Curr Opin Nephrol Hypertens; 1995 Jan; 4(1):1-7. PubMed ID: 7743153
    [No Abstract]   [Full Text] [Related]  

  • 3. Apoptosis and vascular wall remodeling in hypertension.
    Hamet P; deBlois D; Dam TV; Richard L; Teiger E; Tea BS; Orlov SN; Tremblay J
    Can J Physiol Pharmacol; 1996 Jul; 74(7):850-61. PubMed ID: 8946072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II and cell cycle regulation.
    Wolf G; Wenzel UO
    Hypertension; 2004 Apr; 43(4):693-8. PubMed ID: 14967829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered insulin-like growth factor-1 and nitric oxide sensitivities in hypertension contribute to vascular hyperplasia.
    Nolan BP; Senechal P; Waqar S; Myers J; Standley CA; Standley PR
    Am J Hypertens; 2003 May; 16(5 Pt 1):393-400. PubMed ID: 12745202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension.
    Ueno H; Kanellakis P; Agrotis A; Bobik A
    Hypertension; 2000 Jul; 36(1):89-96. PubMed ID: 10904018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension.
    Stenmark KR; Frid MG; Graham BB; Tuder RM
    Cardiovasc Res; 2018 Mar; 114(4):551-564. PubMed ID: 29385432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulation and apoptosis.
    King KL; Cidlowski JA
    Annu Rev Physiol; 1998; 60():601-17. PubMed ID: 9558478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, p21(WAF1/CIP1), and MDM2 involvement in proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells.
    Hsieh JK; Kletsas D; Clunn G; Hughes AD; Schachter M; Demoliou-Mason C
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):636-44. PubMed ID: 10712385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques.
    Bennett MR; Macdonald K; Chan SW; Boyle JJ; Weissberg PL
    Circ Res; 1998 Apr; 82(6):704-12. PubMed ID: 9546379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in target organs of hypertension.
    Hamet P; Richard L; Dam TV; Teiger E; Orlov SN; Gaboury L; Gossard F; Tremblay J
    Hypertension; 1995 Oct; 26(4):642-8. PubMed ID: 7558225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension.
    Cao Y; Li H; Mu FT; Ebisui O; Funder JW; Liu JP
    FASEB J; 2002 Jan; 16(1):96-8. PubMed ID: 11772940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The time window of apoptosis: a new component in the therapeutic strategy for cardiovascular remodeling.
    Hamet P; Moreau P; Dam TV; Orlov SN; Tea BS; de Blois D; Tremblay J
    J Hypertens Suppl; 1996 Dec; 14(5):S65-70. PubMed ID: 9120687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gαq-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates proliferation of vascular smooth muscle cells and vascular remodeling in spontaneously hypertensive rats.
    Zhang HG; Cheng YQ; Liu Y; Zhou JZ; Jia Y; Wang XQ; Li XH
    Biol Pharm Bull; 2011; 34(10):1527-32. PubMed ID: 21963491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function.
    Hénaut L; Mary A; Chillon JM; Kamel S; Massy ZA
    Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29844272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of genetic and experimental hypertension.
    Daniel EE
    Clin Invest Med; 1987 Nov; 10(6):543-6. PubMed ID: 2449990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.
    Dzau VJ
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):27-32. PubMed ID: 7922163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
    Kim GR; Cho SN; Kim HS; Yu SY; Choi SY; Ryu Y; Lin MQ; Jin L; Kee HJ; Jeong MH
    J Hypertens; 2016 Nov; 34(11):2206-19. PubMed ID: 27512969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells.
    Owens GK
    Am J Physiol; 1989 Dec; 257(6 Pt 2):H1755-65. PubMed ID: 2690643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered regulation of smooth muscle cell proliferation and apoptosis in small arteries of spontaneously hypertensive rats.
    Díez J; Fortuño MA; Zalba G; Etayo JC; Fortuño A; Ravassa S; Beaumont J
    Eur Heart J; 1998 Jul; 19 Suppl G():G29-33. PubMed ID: 9717053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.